Filtros : "Therapeutic Delivery" Limpar

Filtros



Limitar por data


  • Fonte: Therapeutic Delivery. Unidade: FOB

    Assuntos: ESTOMATITE SOB PRÓTESE, CANDIDÍASE, CLOREXIDINA, ANTIFÚNGICOS

    PrivadoAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SCHOEFFEL, Amanda Cristina et al. Characterization and antifungal activity of chlorhexidine: β-cyclodextrin inclusion complexes. Therapeutic Delivery, v. 14, n. 4, p. 295-309, 2023Tradução . . Disponível em: https://doi.org/10.4155/tde-2022-0068. Acesso em: 26 jun. 2025.
    • APA

      Schoeffel, A. C., Morikava, F. S., Urban, A. M., Novatski, A., Moraes, G. S., Matioli, G., et al. (2023). Characterization and antifungal activity of chlorhexidine: β-cyclodextrin inclusion complexes. Therapeutic Delivery, 14( 4), 295-309. doi:10.4155/tde-2022-0068
    • NLM

      Schoeffel AC, Morikava FS, Urban AM, Novatski A, Moraes GS, Matioli G, Ferrari PC, Neppelenbroek KH, Farago PV, Urban VM. Characterization and antifungal activity of chlorhexidine: β-cyclodextrin inclusion complexes [Internet]. Therapeutic Delivery. 2023 ; 14( 4): 295-309.[citado 2025 jun. 26 ] Available from: https://doi.org/10.4155/tde-2022-0068
    • Vancouver

      Schoeffel AC, Morikava FS, Urban AM, Novatski A, Moraes GS, Matioli G, Ferrari PC, Neppelenbroek KH, Farago PV, Urban VM. Characterization and antifungal activity of chlorhexidine: β-cyclodextrin inclusion complexes [Internet]. Therapeutic Delivery. 2023 ; 14( 4): 295-309.[citado 2025 jun. 26 ] Available from: https://doi.org/10.4155/tde-2022-0068
  • Fonte: Therapeutic Delivery. Unidades: FOB, HRAC

    Assuntos: CANDIDA ALBICANS, BIOFILMES, PRÓTESE DENTÁRIA, AGENTES ANTIMICROBIANOS, PRODUTOS NATURAIS

    Versão AceitaAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      RUIZ GARCIA, Cindy et al. Effect of denture liners surface modification with Equisetum giganteum and Punica granatum on Candida albicans biofilm inhibition. Therapeutic Delivery, v. 13, n. 3, p. 157-166, 2022Tradução . . Disponível em: https://doi.org/10.4155/tde-2021-0074. Acesso em: 26 jun. 2025.
    • APA

      Ruiz Garcia, C., Ueda, T. Y., Silva, R. A. da, Cano, I. P., Saldanha, L. L., Dokkedal, A. L., et al. (2022). Effect of denture liners surface modification with Equisetum giganteum and Punica granatum on Candida albicans biofilm inhibition. Therapeutic Delivery, 13( 3), 157-166. doi:10.4155/tde-2021-0074
    • NLM

      Ruiz Garcia C, Ueda TY, Silva RA da, Cano IP, Saldanha LL, Dokkedal AL, Porto VC, Urban VM, Neppelenbroek KH. Effect of denture liners surface modification with Equisetum giganteum and Punica granatum on Candida albicans biofilm inhibition [Internet]. Therapeutic Delivery. 2022 ; 13( 3): 157-166.[citado 2025 jun. 26 ] Available from: https://doi.org/10.4155/tde-2021-0074
    • Vancouver

      Ruiz Garcia C, Ueda TY, Silva RA da, Cano IP, Saldanha LL, Dokkedal AL, Porto VC, Urban VM, Neppelenbroek KH. Effect of denture liners surface modification with Equisetum giganteum and Punica granatum on Candida albicans biofilm inhibition [Internet]. Therapeutic Delivery. 2022 ; 13( 3): 157-166.[citado 2025 jun. 26 ] Available from: https://doi.org/10.4155/tde-2021-0074
  • Fonte: Therapeutic Delivery. Unidade: FMRP

    Assuntos: CÉLULAS, DOENÇAS INFECCIOSAS, FUNGOS

    PrivadoAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SILVA, Thiago Aparecido da. CAR T Cell-therapy for infectious diseases with emphasis on invasive fungal infections [Editorial]. Therapeutic Delivery. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.4155/tde-2021-0046. Acesso em: 26 jun. 2025. , 2021
    • APA

      Silva, T. A. da. (2021). CAR T Cell-therapy for infectious diseases with emphasis on invasive fungal infections [Editorial]. Therapeutic Delivery. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.4155/tde-2021-0046
    • NLM

      Silva TA da. CAR T Cell-therapy for infectious diseases with emphasis on invasive fungal infections [Editorial] [Internet]. Therapeutic Delivery. 2021 ; 12( 9): 627-630.[citado 2025 jun. 26 ] Available from: https://doi.org/10.4155/tde-2021-0046
    • Vancouver

      Silva TA da. CAR T Cell-therapy for infectious diseases with emphasis on invasive fungal infections [Editorial] [Internet]. Therapeutic Delivery. 2021 ; 12( 9): 627-630.[citado 2025 jun. 26 ] Available from: https://doi.org/10.4155/tde-2021-0046
  • Fonte: Therapeutic Delivery. Unidade: FCF

    Assuntos: NANOPARTÍCULAS, GELATINA

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SARFRAZ, Muhammad et al. Immune response to antituberculosis drug-loaded gelatin and polyisobutyl-cyanoacrylate nanoparticles in macrophages. Therapeutic Delivery, v. 7, n. 4, p. 213-228, 2016Tradução . . Disponível em: https://doi.org/10.4155/tde-2015-0007. Acesso em: 26 jun. 2025.
    • APA

      Sarfraz, M., Shi, W., Gao, Y., Clas, S. D., Roa, W., & Bou-Chacra, N. A. (2016). Immune response to antituberculosis drug-loaded gelatin and polyisobutyl-cyanoacrylate nanoparticles in macrophages. Therapeutic Delivery, 7( 4), 213-228. doi:10.4155/tde-2015-0007
    • NLM

      Sarfraz M, Shi W, Gao Y, Clas SD, Roa W, Bou-Chacra NA. Immune response to antituberculosis drug-loaded gelatin and polyisobutyl-cyanoacrylate nanoparticles in macrophages [Internet]. Therapeutic Delivery. 2016 ; 7( 4): 213-228.[citado 2025 jun. 26 ] Available from: https://doi.org/10.4155/tde-2015-0007
    • Vancouver

      Sarfraz M, Shi W, Gao Y, Clas SD, Roa W, Bou-Chacra NA. Immune response to antituberculosis drug-loaded gelatin and polyisobutyl-cyanoacrylate nanoparticles in macrophages [Internet]. Therapeutic Delivery. 2016 ; 7( 4): 213-228.[citado 2025 jun. 26 ] Available from: https://doi.org/10.4155/tde-2015-0007
  • Fonte: Therapeutic Delivery. Unidades: ICB, FCFRP

    Assuntos: FARMACOLOGIA, PELE

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LOPES, Luciana Biagini e GARCIA, Maria Teresa Junqueira e BENTLEY, Maria Vitoria Lopes Badra. Chemical penetration enhancers. Therapeutic Delivery, v. 6, n. 9, p. 1053-1061, 2015Tradução . . Disponível em: https://doi.org/10.4155/tde.15.61. Acesso em: 26 jun. 2025.
    • APA

      Lopes, L. B., Garcia, M. T. J., & Bentley, M. V. L. B. (2015). Chemical penetration enhancers. Therapeutic Delivery, 6( 9), 1053-1061. doi:10.4155/tde.15.61
    • NLM

      Lopes LB, Garcia MTJ, Bentley MVLB. Chemical penetration enhancers [Internet]. Therapeutic Delivery. 2015 ; 6( 9): 1053-1061.[citado 2025 jun. 26 ] Available from: https://doi.org/10.4155/tde.15.61
    • Vancouver

      Lopes LB, Garcia MTJ, Bentley MVLB. Chemical penetration enhancers [Internet]. Therapeutic Delivery. 2015 ; 6( 9): 1053-1061.[citado 2025 jun. 26 ] Available from: https://doi.org/10.4155/tde.15.61

Biblioteca Digital de Produção Intelectual da Universidade de São Paulo     2012 - 2025